Dr. Michael Nelson, PhD
Claim this profileClinical Trials Michael Nelson, PhD is currently running
More about Michael Nelson, PhD
Clinical Trial Related
11 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Michael Nelson, PhD has experience with
- Altitude Simulation
- Handgrip
- Leg Exercise
Breakdown of trials Michael Nelson, PhD has run
Coronary microvascular disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Nelson, PhD specialize in?
Michael Nelson, PhD focuses on Coronary microvascular disease and other conditions. In particular, much of their work with Coronary microvascular disease has involved treating patients, or patients who are undergoing treatment.
Is Michael Nelson, PhD currently recruiting for clinical trials?
Yes, Michael Nelson, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Michael Nelson, PhD has studied deeply?
Yes, Michael Nelson, PhD has studied treatments such as Altitude simulation, Handgrip, Leg exercise.
What is the best way to schedule an appointment with Michael Nelson, PhD?
Apply for one of the trials that Michael Nelson, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.